Powder: -20°C for 3 years | In solvent: -80°C for 1 year
ROCK-IN-2 (Azaindole 1) is a selective and ATP-competitive ROCK inhibitor with IC50 of 0.6 and 1.1 nM for human ROCK-1 and ROCK-2.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 27,000 | |||
5 mg | 在庫あり | ¥ 66,500 | |||
10 mg | 在庫あり | ¥ 106,500 | |||
25 mg | 在庫あり | ¥ 176,000 | |||
50 mg | 在庫あり | ¥ 245,500 | |||
100 mg | 在庫あり | ¥ 333,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 90,000 |
説明 | ROCK-IN-2 (Azaindole 1) is a selective and ATP-competitive ROCK inhibitor with IC50 of 0.6 and 1.1 nM for human ROCK-1 and ROCK-2. |
ターゲット&IC50 | ROCK1:0.6 nM (cell free), ROCK2:1.1 nM (cell free) |
In vitro | Azaindole 1 a highly potent inhibitor of human ROCK-1 and ROCK-2 (IC50s: 0.6 and 1.1?nM) and also inhibits murine ROCK-2 or rat ROCK-2 (IC50s: 2.4 and 0.8?nM). Azaindole 1 also inhibits receptor tyrosine kinases TRK and FLT3, with IC50s of 252 and 303?nM, respectively, but shows slight inhibition of MLCK and ZIP-kinase with IC50s of 7.4?μM and 4.1?μM, respectively. Azaindole 1 induces vasorelaxation in vitro and suppresses the phenylephrine-induced contraction of the rabbit saphenous artery in a concentration-dependent manner (IC50: 65?nM). |
In vivo | Azaindole 1 (0.03, 0.1, 0.3?mg/kg, i.v.) results in a dose-dependent and long-lasting decrease in blood pressure in anaesthetized normotensive rats. Azaindole 1 (3 and 10?mg/kg, p.o.) decreases blood pressure dose-dependently and persistently both in normotensive and hypertensive rats and shows such effects even at 1?mg/kg in hypertensive rats. Azaindole 1 (0.1 and 0.3?mg/kg, i.v. bolus injections) causes decreased mean arterial blood pressure in a dose-related manner and only leads to a moderate and dose-independent increase in heart rate of anesthetized dogs. |
動物実験 | Male Wistar rats (300-350?g) are anesthetized with thiopental 100?mg/kg intraperitoneally (i.p.). A tracheotomy is performed and catheters are inserted into the femoral artery for blood pressure and heart rate measurements and into the femoral vein for test drug administration. The animals are ventilated with room air and their body temperature is controlled. Azaindole 1 is administered intravenously (i.v.) in doses of 0.03-0.1?mg/kg. The vehicle Transcutol/Cremophor EL/physiological saline (19/10/80 = v/v/v) without test drug is used as control. The volume administered is 1?mL/kg. Six animals are treated per group. |
別名 | TC-S 7001, Azaindole 1 |
分子量 | 402.79 |
分子式 | C18H13ClF2N6O |
CAS No. | 867017-68-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: Insoluble
DMSO: 30 mg/mL (74.48 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
ROCK-IN-2 867017-68-3 Cell Cycle/Checkpoint Cytoskeletal Signaling Stem Cells ROCK inhibit Rho-kinase Rho-associated protein kinase Azaindole-1 ROCKIN2 Rho-associated kinase Inhibitor TC-S 7001 ROCK IN 2 TC-S-7001 TC-S7001 Azaindole1 ROK Azaindole 1 inhibitor